ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
ADMA Biologics (ADMA) - P/B ratio
P/B ratio as of May 2024 : 11.6
According to ADMA Biologics
's latest financial reports the company has a price-to-book ratio of 11.6.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ADMA Biologics - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 7.55 | 33.94% |
| 2022-12-31 | 5.64 | 188.37% |
| 2021-12-31 | 1.96 | -6.39% |
| 2020-12-31 | 2.09 | -76.94% |
| 2019-12-31 | 9.06 | 61.67% |
| 2018-12-31 | 5.60 | 55.36% |
| 2017-12-31 | 3.61 | -124.36% |
| 2016-12-31 | -14.8 | -114.06% |
| 2015-12-31 | 105 | 509.65% |
| 2014-12-31 | 17.3 | 414.16% |
| 2013-12-31 | 3.36 | |
| 2012-12-31 | N/A | |
| 2011-12-31 | N/A | |
| 2010-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 4.71 | -59.22% | 🇺🇸 USA |
 Novavax NVAX | -0.9224 | -107.98% | 🇺🇸 USA |
 Cel-Sci
CVM | 6.32 | -45.34% | 🇺🇸 USA |